# Satsuma Pharmaceuticals Inc. (STSA)

Source: https://www.quantisnow.com/company/STSA
Generated: 2026-11-09T21:59:19.227Z

- Ticker: STSA
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2019
- Website: satsumarx.com

## About

Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. Its lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in ASCEND Phase III clinical trials and can be self-administered with proprietary pre-filled, single-use, and nasal delivery device. The company was incorporated in 2016 and is headquartered in South San Francisco, California.

## Latest STSA news and filings

- 2023-06-20 17:02 UTC [SEC Form 15-12G filed by Satsuma Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-satsuma-pharmaceuticals-inc-4660775)
- 2023-06-15 12:00 UTC [Satsuma Pharmaceuticals and SNBL Announce Three Abstracts on STS101 for the Acute Treatment of Migraine to be Presented at the American Headache Society's 65th Annual Scientific Meeting](https://www.quantisnow.com/insight/satsuma-pharmaceuticals-and-snbl-announce-three-abstracts-on-sts101-for-4644691)
- 2023-06-13 00:23 UTC [SEC Form 4] [SEC Form 4 filed by Ra Capital Management, L.P.](https://www.quantisnow.com/insight/sec-form-4-filed-by-ra-capital-management-lp-4632427)
- 2023-06-12 21:00 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Satsuma Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-satsuma-pharmaceuticals-inc-amendment-4631643)
- 2023-06-09 11:30 UTC [Market Insight] [Satsuma Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying](https://www.quantisnow.com/insight/satsuma-pharmaceuticals-and-2-other-penny-stocks-insiders-are-aggressively-4623170)
- 2023-06-09 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Satsuma Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-satsuma-pharmaceuticals-inc-4622929)
- 2023-06-09 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Satsuma Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-satsuma-pharmaceuticals-inc-4622928)
- 2023-06-09 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Satsuma Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-satsuma-pharmaceuticals-inc-4622863)
- 2023-06-08 20:48 UTC [SEC Form 4] [SEC Form 4 filed by O'Neil Thomas P.](https://www.quantisnow.com/insight/sec-form-4-filed-by-oneil-thomas-p-4621634)
- 2023-06-08 20:45 UTC [SEC Form 4] [SEC Form 4 filed by Shah Rajeev M.](https://www.quantisnow.com/insight/sec-form-4-filed-by-shah-rajeev-m-4621601)
- 2023-06-08 20:44 UTC [SEC Form 4] [SEC Form 4 filed by Takanashi Ken](https://www.quantisnow.com/insight/sec-form-4-filed-by-takanashi-ken-4621585)
- 2023-06-08 20:43 UTC [SEC Form 4] [SEC Form 4 filed by Riebe Michael T](https://www.quantisnow.com/insight/sec-form-4-filed-by-riebe-michael-t-4621580)
- 2023-06-08 20:38 UTC [SEC Form 4] [SEC Form 4 filed by Sandoval Elisabeth](https://www.quantisnow.com/insight/sec-form-4-filed-by-sandoval-elisabeth-4621507)
- 2023-06-08 20:37 UTC [SEC Form 4] [SEC Form 4 filed by Soloway Thomas P](https://www.quantisnow.com/insight/sec-form-4-filed-by-soloway-thomas-p-4621498)
- 2023-06-08 20:31 UTC [SEC Form 4] [SEC Form 4 filed by Kollins John A](https://www.quantisnow.com/insight/sec-form-4-filed-by-kollins-john-a-4621415)
- 2023-06-08 20:31 UTC [SEC Form 4] [SEC Form 4 filed by Lukatch Heath](https://www.quantisnow.com/insight/sec-form-4-filed-by-lukatch-heath-4621393)
- 2023-06-08 20:30 UTC [SEC Form 4] [SEC Form 4 filed by King Thomas Braxton](https://www.quantisnow.com/insight/sec-form-4-filed-by-king-thomas-braxton-4621338)
- 2023-06-08 20:24 UTC [SEC Form 4] [SEC Form 4 filed by Shin Nippon Biomedical Laboratories, Ltd.](https://www.quantisnow.com/insight/sec-form-4-filed-by-shin-nippon-biomedical-laboratories-ltd-4621217)
- 2023-06-08 20:17 UTC [SEC Form 4] [SEC Form 4 filed by Harsch Mutya](https://www.quantisnow.com/insight/sec-form-4-filed-by-harsch-mutya-4621108)
- 2023-06-08 13:26 UTC [SEC Form 25-NSE filed by Satsuma Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-satsuma-pharmaceuticals-inc-4618746)
- 2023-06-08 13:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Satsuma Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-satsuma-pharmaceuticals-inc-4618725)
- 2023-06-08 13:21 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Satsuma Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-satsuma-pharmaceuticals-inc-4618720)
- 2023-06-08 13:19 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Satsuma Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-satsuma-pharmaceuticals-inc-4618710)
- 2023-06-08 13:18 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Satsuma Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-satsuma-pharmaceuticals-inc-4618704)
- 2023-06-08 13:17 UTC [SEC Form POS AM filed by Satsuma Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-satsuma-pharmaceuticals-inc-4618698)
- 2023-06-08 13:17 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Satsuma Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-satsuma-pharmaceuticals-inc-amendment-4618697)
- 2023-06-08 13:16 UTC [SEC Form POS AM filed by Satsuma Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-satsuma-pharmaceuticals-inc-4618691)
- 2023-06-08 13:16 UTC [SEC Schedule TOT] [SEC Form SC TO-T/A filed by Satsuma Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-to-ta-filed-by-satsuma-pharmaceuticals-inc-amendment-4618687)
- 2023-06-08 13:14 UTC [SEC Form POS AM filed by Satsuma Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-satsuma-pharmaceuticals-inc-4618681)
- 2023-06-08 13:13 UTC [SEC Form 8-K] [Satsuma Pharmaceuticals Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/satsuma-pharmaceuticals-inc-filed-sec-form-8-k-termination-of-a-4618667)
- 2023-06-08 13:12 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Satsuma Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-satsuma-pharmaceuticals-inc-amendment-4618661)
- 2023-06-08 13:11 UTC [SEC Form SC 13E3/A filed by Satsuma Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13e3a-filed-by-satsuma-pharmaceuticals-inc-amendment-4618658)
- 2023-05-31 01:42 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Satsuma Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-satsuma-pharmaceuticals-inc-amendment-4579681)
- 2023-05-31 01:47 UTC [SEC Form SC 13E3/A filed by Satsuma Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13e3a-filed-by-satsuma-pharmaceuticals-inc-amendment-4579657)
- 2023-05-26 10:39 UTC [SEC Schedule TOT] [SEC Form SC TO-T/A filed by Satsuma Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-to-ta-filed-by-satsuma-pharmaceuticals-inc-amendment-4563577)
- 2023-05-25 01:40 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Satsuma Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-satsuma-pharmaceuticals-inc-amendment-4555841)
- 2023-05-25 01:44 UTC [SEC Form SC 13E3/A filed by Satsuma Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13e3a-filed-by-satsuma-pharmaceuticals-inc-amendment-4555782)
- 2023-05-18 21:14 UTC [SEC Form SC 13E3/A filed by Satsuma Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13e3a-filed-by-satsuma-pharmaceuticals-inc-amendment-4529059)
- 2023-05-18 21:06 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Satsuma Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-satsuma-pharmaceuticals-inc-amendment-4528964)
- 2023-05-18 20:20 UTC [SEC Form 8-K] [Satsuma Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/satsuma-pharmaceuticals-inc-filed-sec-form-8-k-other-events-financial-4528250)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/STSA
- Earnings history: https://www.quantisnow.com/earnings/STSA
- Dividend history: https://www.quantisnow.com/dividends/STSA
- Insider transactions: https://www.quantisnow.com/insiders/STSA
- Options chain: https://www.quantisnow.com/options/STSA
- SEC 8-K filings only: https://www.quantisnow.com/company/STSA/8-k
- RSS and alerts for STSA: https://www.quantisnow.com/docs/rss-feeds.md